Saturna Capital Corp Purchases 1,000 Shares of Colgate-Palmolive (NYSE:CL)

Saturna Capital Corp boosted its position in Colgate-Palmolive (NYSE:CL) by 0.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 490,200 shares of the company’s stock after purchasing an additional 1,000 shares during the period. Saturna Capital Corp owned about 0.06% of Colgate-Palmolive worth $44,564,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Kohmann Bosshard Financial Services LLC bought a new position in Colgate-Palmolive in the 4th quarter worth $26,000. Centricity Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth approximately $27,000. Union Bancaire Privee UBP SA purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth $32,000. Briaud Financial Planning Inc bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $32,000. Finally, OFI Invest Asset Management purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at $36,000. 80.41% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have commented on CL shares. Raymond James reissued an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Morgan Stanley decreased their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. UBS Group dropped their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Piper Sandler reduced their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Finally, Barclays lowered their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.61.

Colgate-Palmolive Price Performance

NYSE:CL opened at $94.05 on Wednesday. The firm has a market capitalization of $76.32 billion, a price-to-earnings ratio of 26.72, a PEG ratio of 4.20 and a beta of 0.40. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The business has a 50 day simple moving average of $89.03 and a 200-day simple moving average of $94.99. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the firm earned $0.87 earnings per share. Equities analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.